Senores Pharmaceuticals IPO

Senores Pharmaceuticals IPO

The Senores Pharmaceuticals IPO is a book-built issue worth ₹582.11 crores, comprising a fresh issue of 1.28 crore shares aggregating to ₹500.00 crores and an offer for sale of 0.21 crore shares aggregating to ₹82.11 crores.

The IPO opens for subscription on December 20, 2024, and closes on December 24, 2024. The allotment is expected to be finalized on Thursday, December 26, 2024, with a tentative listing date of Monday, December 30, 2024, on the BSE and NSE.

The price band for the IPO is ₹372 to ₹391 per share, with a minimum lot size of 38 shares.

  • Retail Investors: Minimum investment is ₹14,858.
  • sNII: Minimum investment is ₹2,08,012 (14 lots, 532 shares).
  • bNII: Minimum investment is ₹10,10,344 (68 lots, 2,584 shares).

For detailed information about the Senores Pharmaceuticals IPO RHP, please refer to the Red Herring Prospectus (RHP). The RHP provides comprehensive details about the company’s financials, business operations, risks, and other critical aspects of the IPO.

Senores Pharmaceuticals IPO Details

IPO DateDecember 20, 2024 to December 24, 2024
Face Value₹10 per share
Price Band₹372 to ₹391 per share
Lot Size38 Shares
Total Issue Size1,48,87,723 shares
(aggregating up to ₹582.11 Cr)
Fresh Issue1,27,87,723 shares
(aggregating up to ₹ 500.00 Cr)
Offer for Sale21,00,000 shares of ₹10
(aggregating up to ₹82.11 Cr)
Issue TypeBook Built Issue IPO
Listing AtBSE, NSE
Share Holding Pre Issue3,32,65,865 shares
Share Holding Post Issue4,60,53,588 shares

Senores Pharmaceuticals IPO Timeline

The Senores Pharmaceuticals IPO opens on December 20, 2024, and closes on December 24, 2024.

IPO Open DateFriday, December 20, 2024
IPO Close DateTuesday, December 24, 2024
Basis of AllotmentThursday, December 26, 2024
Initiation of RefundsFriday, December 27, 2024
Credit of Shares to DematFriday, December 27, 2024
Listing DateMonday, December 30, 2024

Senores Pharmaceuticals IPO Lot Size

Investors can bid for a minimum of 38 shares and in multiples thereof. The table below outlines the minimum and maximum investment for retail investors and HNIs in terms of shares and amounts:

ApplicationLotsSharesAmount
Retail (Min)138₹14,858
Retail (Max)13494₹1,93,154
S-HNI (Min)14532₹2,08,012
S-HNI (Max)672,546₹9,95,486
B-HNI (Min)682,584₹10,10,344

Senores Pharmaceuticals IPO Reservation

Investor CategoryShares OfferedMaximum Allottees 
Anchor Investor Shares Offered66,65,725 (45%)NA
QIB Shares Offered44,43,817 (30%)NA
NII (HNI) Shares Offered22,21,909 (15%)
  bNII > ₹10L15,18,605 (10.25%)2,854
  sNII < ₹10L7,03,304 (4.75%)1,322
Retail Shares Offered14,81,272 (10%)38,980
Total Shares Offered1,48,12,723 (100%)

About Senores Pharmaceuticals Limited

Senores Pharmaceuticals Limited, incorporated in December 2017, develops and manufactures a wide range of pharmaceutical products for regulated markets such as the US, Canada, and the UK, as well as for emerging markets.

The company’s product portfolio includes Amphetamine Sulfate Tablets, Hydroxychloroquine Sulfate Tablets, Ketoconazole Tablets, and several other critical medicines for regulated markets. As of September 30, 2024, it has launched 55 products in key therapeutic areas, including antibiotics and anti-fungal treatments, and has built partnerships with distributors and hospitals across India.

The company operates three R&D facilities located in India and the US and manufactures critical care injectables and APIs. Its manufacturing unit is situated in Ahmedabad, Gujarat, and the company has a presence in 43 countries within emerging markets.

Senores Pharmaceuticals IPO FAQs

What is the Senores Pharmaceuticals IPO?

The Senores Pharmaceuticals IPO is a main-board issue of 14,887,723 equity shares with a face value of ₹10, aggregating up to ₹582.11 crores. The price band is set at ₹372 to ₹391 per share, and the minimum order quantity is 38 shares.

The IPO will open on December 20, 2024, and close on December 24, 2024.

Link Intime India Private Ltd is the registrar for the IPO, and the shares are proposed to be listed on BSE and NSE.

When Senores Pharmaceuticals IPO will open?

The Senores Pharmaceuticals IPO opens on December 20, 2024, and closes on December 24, 2024.

What is the lot size of Senores Pharmaceuticals IPO?

The Senores Pharmaceuticals IPO has a lot size of 38 shares, and the minimum investment amount required is ₹14,858.

When is Senores Pharmaceuticals IPO allotment?

The finalization of the Basis of Allotment for the Senores Pharmaceuticals IPO will be completed on Thursday, December 26, 2024, and the allotted shares will be credited to your demat account by Friday, December 27, 2024.

When is Senores Pharmaceuticals IPO listing date?

The **Senores Pharmaceuticals IPO** listing date is **Monday, December 30, 2024**.

Scroll to Top
Rexpro Enterprises IPO – Opens on 22 Jan 2025 Capital Numbers Infotech IPO Details Stallion India IPO Details Learn how to close your Demat account with this step-by-step guide EMA Partners IPO to Open on January 17: Key Details Announced – IPO Spy